chitosan has been researched along with cabazitaxel in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chuan, D; Fan, R; Guo, G; Han, B; Liang, X; Mu, M; Tong, A; Yu, W; Zhao, N; Zhao, S | 1 |
| Behera, C; Kumari, P; Mahto, SK; Mehata, AK; Muthu, MS; Suseela, MNL | 1 |
2 other study(ies) available for chitosan and cabazitaxel
| Article | Year |
|---|---|
Chitosan coated pH-responsive metal-polyphenol delivery platform for melanoma chemotherapy.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Chitosan; Drug Carriers; Drug Delivery Systems; Drug Liberation; Hydrogen-Ion Concentration; Ki-67 Antigen; Melanoma; Metal Nanoparticles; Mice; Particle Size; Platelet Endothelial Cell Adhesion Molecule-1; Polyphenols; Taxoids; Tumor Microenvironment | 2021 |
Chitosan-alginate nanoparticles of cabazitaxel: Design, dual-receptor targeting and efficacy in lung cancer model.
Topics: Alginates; Animals; Cell Line, Tumor; Chitosan; Folic Acid; Lung Neoplasms; Mice; Nanoparticles; Rats; Rats, Wistar | 2022 |